L-377202
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for L-377202, covering 2023-05-25 to 2023-05-25. Get the full timeline:
Most recent: Clinical Trial Update: Study Evaluating the Safety and Tolerability of L-377202 [Phase 1, Phase 2]